News
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best hot stocks to buy according to Wall Street analysts. On July 3, ...
Revolution Medicines Inc. (NASDAQ:RVMD) is one of the best high short interest stocks with huge upside potential. On June 30, ...
Summit Therapeutics (NASDAQ:SMMT) shares spiked on Thursday, triggering a trading halt after Bloomberg News reported that ...
Summit Therapeutics Inc. (NASDAQ: SMMT) is one of the best hot stocks to buy according to Wall Street analysts. On July 3, ...
10h
Zacks.com on MSNSMMT Stock Gains on Rumored Licensing Talks With AstraZenecaSummit Therapeutics jumps 9% as AZN eyes a potential $15 billion licensing deal for its cancer drug, ivonescimab.
Especially high volume was seen for the $25 strike call option expiring July 18, 2025, with 1,411 contracts trading so far today, representing approximately 141,100 underlying shares of SMMT.
4d
InvestorsHub on MSNSummit Therapeutics Shares Climb Amid Rumored $15B Deal Talks with AstraZenecaShares of Summit Therapeutics (NASDAQ:SMMT) jumped 5% on Thursday following reports that the company is in advanced ...
Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the 30 stocks expected to beat the market by 20 percentage points this ...
Shares of Summit Therapeutics PLC (SMMT) have gained 2.8% over the past four weeks to close the last trading session at $21.2, but there could still be a solid upside left in the stock if short ...
The latest price target for Summit Therapeutics (NASDAQ:SMMT) was reported by UBS on July 1, 2025. The analyst firm set a price target for $30.00 expecting SMMT to rise to within 12 months (a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results